Comorbidities of mental and behavioral disorders in chemically dependent patients in different periods of abstinence

Jornal Brasileiro de Psiquiatria

Maria De Lourdes Pereira Costa²  Luiz Carlos Marques De Oliveira¹ 

[1] ,Universidade Federal de Uberlândia Centro de Atenção Psicossocial de Álcool e Outras Drogas (CAPS-ad) David Capistrano da Costa Filho Programa de Atenção à Pessoa com Dependência Química

关键词: Comorbidity;    diagnosis;    dual;    dependency;    alcoholism;    Comorbidade;    diagnóstico duplo;    dependência;    alcoolismo;   

DOI  :  10.1590/S0047-20852012000300004

来源: SciELO

【 摘 要 】

OBJECTIVE: To assess the frequency of comorbidities of mental and behavioral disorders (CMBD) in psychoactive substance (PAS)-dependent patients with different periods of abstinence cared for at Alcohol and Other Drug Psychosocial Care Centers (CAPS-ad). METHOD: All patients under treatment in the two CAPS-ad of the city of Uberlândia-MG, between April and September 2010, were consecutively assessed. The ICD-10 symptom checklist was used to diagnose CMBD; additional information was obtained from interviews and medical records. The patients were divided according to duration of abstinence: < 1 week (Group 1); 1-4 weeks (Group 2); and > 4 weeks (Group 3). RESULTS: Of all patients assessed, 62.8% were diagnosed with CMBD, which were more frequent (p < 0.05) in Group 1 (72%) than Group 3 (54.2%), and both groups were similar to Group 2 (61%). Depressive and anxiety disorders were more frequent among patients of Group 1. Mood disorders were more frequent (p < 0.05) in women [22/34 (65%) vs. 54/154 (35.1%)], whereas psychotic disorders were more frequent (p = 0.05) in men [16/154 (10.4%) vs. 0]. The presence of CMBD was associated with more severe clinical conditions. CONCLUSIONS: The higher frequency of diagnosis of CMBD in patients of Group 1 may have resulted from the difficulties in distinguishing mental disorders that are due to PAS intoxication or withdrawal from those that are not. However, to make the diagnosis of CMBD, even during detoxification, can increase the likelihood of better response to treatment.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License